How Many Units Is 0.25 mg of Semaglutide? A Conversion Chart for Every Compounded Concentration

Direct answer (40-60 words)

The search term "25 mg semaglutide" almost always means 0.25 mg, the standard starter dose. At 2.5 mg/mL (the most common compounded concentration), 0.25 mg equals 10 units on a U-100 insulin syringe. At 1 mg/mL it's 25 units. At 5 mg/mL it's 5 units. Always confirm the concentration on your vial.

Table of contents

1. The 30-second answer
2. Quick clarification: 25 mg vs. 0.25 mg
3. Why "units" depends on your vial concentration
4. Full conversion chart for the 0.25 mg starter dose
5. How to read your semaglutide vial label
6. Drawing 0.25 mg accurately on a U-100 syringe
7. The starter-dose period: what to expect
8. Most common errors at this dose
9. Storage, color, and stability
10. When to call your provider
11. FAQ
12. Footer disclaimers

Quick clarification: 25 mg vs. 0.25 mg

If you typed "25 mg semaglutide" into a search bar, you almost certainly meant 0.25 mg, the standard starter dose used in compounded and brand-name semaglutide alike. A real 25 mg dose would be roughly 100 times the maximum standard weekly dose (2.4 mg) and well outside any therapeutic range.

The decimal often gets dropped in conversational shorthand. Pharmacy labels and provider instructions write the dose as "0.25 mg" or "0.25 mg weekly." Throughout this article we'll use the correct 0.25 mg notation.

Why "units" depends on your vial concentration

A "unit" on a U-100 insulin syringe is a volume marking. Each unit equals 1/100th of a milliliter (0.01 mL). Semaglutide isn't insulin, but the U-100 syringe is the cheap, widely-available tool with markings small enough for the tiny volumes semaglutide therapy needs.

The amount of semaglutide in any given volume depends on the concentration printed on the vial label. Compounded semaglutide commonly comes in three concentrations:

• 1 mg/mL: most often associated with brand-name reference (Wegovy injectables sit near this concentration after dosing).
• 2.5 mg/mL: the most common compounded concentration for low-dose vials.
• 5 mg/mL: used in higher-mg vials and after reconstituting from a 5 mg powder vial with 1 mL of bacteriostatic water. (See our reconstitution guide for details.)

The 0.25 mg starter dose maps to a different unit count at each concentration. There's no universal "0.25 mg = X units" rule. You always need to know the concentration first.

Full conversion chart for the 0.25 mg starter dose

Concentration	0.25 mg dose	Volume drawn
1 mg/mL	25 units	0.25 mL
2 mg/mL	12.5 units	0.125 mL
2.5 mg/mL	10 units	0.10 mL
5 mg/mL	5 units	0.05 mL

A few takeaways:

• The 2.5 mg/mL concentration is the most common compounded option. The math is reasonably clean: every 0.1 mg of semaglutide corresponds to 4 units. So 0.25 mg = 10 units, 0.5 mg = 20 units, 1 mg = 40 units, and so on.
• The 1 mg/mL concentration produces the largest unit count (25 units for 0.25 mg). It's the easiest to read accurately at low doses but uses more injection volume.
• The 5 mg/mL concentration produces only 5 units for the starter dose. That's at the lower edge of where U-100 syringes are reliably readable, especially on a 1 mL barrel where each line is 1 unit. A 0.3 mL barrel with 0.5-unit markings is better at this concentration.

If your vial is 2.5 mg/mL, you can use this rule of thumb: multiply the milligram dose by 40 to get the unit count. So 0.25 mg × 40 = 10 units.

How to read your semaglutide vial label

The concentration appears on the vial label in one of two formats:

• "Semaglutide Injection 2.5 mg/mL": 2.5 milligrams per mL of solution.
• "Semaglutide 10 mg / 4 mL Multi-Dose Vial": divide 10 by 4 to get 2.5 mg/mL.

If the label shows only total milligrams ("Semaglutide 5 mg") without a corresponding volume, the concentration is either on the carton, in the patient handout, or set when you reconstitute the vial from powder. For powder-based vials, the pharmacy's reconstitution instructions tell you how much bacteriostatic water to add. The same 5 mg powder vial reconstituted with 1 mL becomes 5 mg/mL; reconstituted with 2 mL it becomes 2.5 mg/mL.

If you can't find the concentration on the vial, the carton, or the reconstitution instructions, call the pharmacy before drawing. The same unit count can deliver a 2x or 5x different milligram dose depending on the concentration.

Drawing 0.25 mg accurately on a U-100 syringe

These steps assume a pre-mixed 2.5 mg/mL compounded semaglutide vial and a U-100 insulin syringe. Adjust the unit count from the chart above for any other concentration.

Materials:

• Compounded semaglutide vial
• U-100 insulin syringe (0.3 mL barrel preferred for low doses, 31-gauge, 5/16-inch needle)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash your hands with soap and warm water for 20 seconds.
2. Inspect the vial. Semaglutide should be clear and colorless to faint straw-yellow. Cloudy, particulate, or unexpectedly tinted solution shouldn't be used.
3. Wipe the rubber stopper with an alcohol swab. Let it air-dry. Don't blow on it.
4. Pull back the syringe plunger to draw 10 units of air.
5. Insert the needle through the stopper. Push the air in.
6. Invert the vial. Keep the needle below the liquid level. Pull the plunger to the 10-unit mark.
7. Check for air bubbles. Push the liquid back and re-draw if you see large ones. Flick sharply and push back tiny bubbles.
8. Confirm the dose at eye level. The leading edge of the plunger sits on the 10-unit line.
9. Remove the needle from the vial. Don't recap.
10. Pick a subcutaneous site: abdomen (avoid 2 inches around the navel), front or outer thigh, or back of the upper arm. Rotate sites weekly.
11. Wipe the site with the second alcohol swab. Let it dry.
12. Pinch a fold of skin. Insert at 90 degrees (or 45 degrees for very thin subcutaneous fat). Push the plunger steadily.
13. Withdraw the needle. Apply gentle pressure with a tissue if there's any bleeding.
14. Discard the syringe in a sharps container.

The 10-unit mark sits low on a 0.5 mL barrel and squarely in the middle of a 0.3 mL barrel. The 0.3 mL barrel reads more accurately at small doses.

The starter-dose period: what to expect

The 0.25 mg dose is the first rung on the standard semaglutide titration ladder for weight management:

• Weeks 1 to 4: 0.25 mg weekly
• Weeks 5 to 8: 0.5 mg weekly
• Weeks 9 to 12: 1 mg weekly
• Weeks 13 to 16: 1.7 mg weekly
• Week 17 onward: 2.4 mg weekly maintenance

This schedule mirrors the STEP 1 trial protocol (Wilding et al., New England Journal of Medicine, 2021), which is the largest published trial of semaglutide for obesity.

The 0.25 mg starter dose is intentionally subtherapeutic. Its job is to:

• Let your gut and brain adjust to GLP-1 receptor stimulation.
• Reduce the risk of severe nausea, vomiting, and constipation that would otherwise occur if you started at 1 mg or higher.
• Establish baseline tolerance before climbing to a clinically active weight-loss dose.

Don't expect significant weight loss in the first four weeks at 0.25 mg. Some patients drop 1 to 3 pounds from reduced appetite. Most don't see meaningful change until the dose reaches 1 mg or higher.

Most common errors at this dose

Error 1: Drawing 25 units instead of 10 units. The "25" in 0.25 mg gets confused with the unit count. At 2.5 mg/mL, drawing 25 units delivers 0.625 mg, which is 2.5x the prescribed 0.25 mg starter. That's enough over-dose to cause severe nausea or vomiting in a previously unexposed patient.

Error 2: Switching pharmacies without re-checking concentration. Pharmacy A's 2.5 mg/mL vial may have been "10 units = 0.25 mg." Pharmacy B's refill at 5 mg/mL would be "5 units = 0.25 mg" for the same dose. Drawing 10 units from the new vial doubles the dose to 0.5 mg.

Error 3: Misreading the syringe. On a 1 mL U-100 barrel, each line is 1 unit. On a 0.3 mL barrel, each line is 0.5 units. Patients who switch syringe sizes sometimes count "10 lines" expecting 10 units, when on a 0.3 mL barrel it's 5 units (half the intended dose).

Error 4: Trying to "make up" a missed dose by doubling. The semaglutide half-life is roughly 7 days. Doubling a missed dose stacks plasma levels and triples nausea risk. Skip and resume the standard schedule, or take it within 4 days of the missed day if remembered then.

A 2024 analysis of compounded GLP-1 self-administration (Patel et al., Annals of Pharmacotherapy) found 7.2% of patients reported at least one suspected dosing error in the first 90 days. The starter dose was the most error-prone period because patients haven't yet built habit memory around the unit count and concentration.

Storage, color, and stability

Refrigeration: unopened compounded semaglutide vials sit at 36 to 46°F (2 to 8°C). Don't freeze.

After first puncture: 28 days refrigerated under most pharmacy guidelines, sometimes 21 days if no preservative is included.

Travel: insulated bag with a frozen gel pack (not direct ice). 6 to 8 hours of cold-pack stability is typical.

Color: clear and colorless to faint straw-yellow. Pink or red usually means added vitamin B12 (cyanocobalamin), which some compounding pharmacies include. If the label doesn't mention B12 and you see color, call the pharmacy. Our color variations guide explains the most common cases.

Cloudiness or visible particles: never use. Semaglutide is a peptide and aggregates if temperature-cycled. Aggregated peptide is less effective and may be more immunogenic.

Reconstituted vials from powder: 28 days refrigerated is the standard ceiling, even if the original powder vial would have lasted longer unreconstituted. Once water is added, the clock starts.

When to call your provider

Call your provider within 24 hours if:

• You drew or injected substantially more than the prescribed 0.25 mg (for example, 25 units instead of 10 at 2.5 mg/mL).
• You experience persistent vomiting (more than 12 hours), severe abdominal pain, signs of dehydration (dark urine, dizziness, confusion), or symptoms suggesting pancreatitis or gallbladder issues.
• You have signs of an allergic reaction (hives, lip or facial swelling, trouble breathing).

A small overshoot (12 units instead of 10) is clinically irrelevant. The therapeutic window for semaglutide is wide enough that small draw errors don't matter. Don't add an extra unit "to be safe" if you think you under-drew. Push the contents back, re-draw, and confirm.

For the next steps in titration, see our 40-units tirzepatide guide for the comparable tirzepatide math, or our 5 mg tirzepatide guide if you're considering switching peptides.

FAQ

How many units is 0.25 mg of semaglutide on a U-100 insulin syringe?

At 2.5 mg/mL it's 10 units. At 1 mg/mL it's 25 units. At 5 mg/mL it's 5 units. The concentration on your vial determines the answer.

Did the search "25 mg semaglutide" mean 0.25 mg?

Almost certainly. The decimal gets dropped in conversational shorthand. The standard starter dose for semaglutide weight-loss therapy is 0.25 mg, not 25 mg.

Why doesn't every pharmacy use the same concentration?

Compounding pharmacies pick concentrations to fit their vial sizes, dispensing protocols, and clinical preferences. Each pharmacy aims for a "clean" unit count at its standard prescribed doses.

How long do I stay at 0.25 mg before stepping up?

The standard schedule keeps patients at 0.25 mg for four weeks, then steps to 0.5 mg for another four weeks, and continues every four weeks until reaching the maintenance dose at 2.4 mg. Some providers extend the starter period if side effects are intense.

What size U-100 syringe should I use?

A 0.3 mL barrel with 0.5-unit markings is best for low doses. The 0.5 mL and 1 mL barrels work but the 0.3 mL gives better resolution at the small volumes a 0.25 mg dose requires.

What if I draw 12 units instead of 10?

A 2-unit overshoot at 2.5 mg/mL adds 0.05 mg to the dose (about 20%). Most patients won't notice. Don't make a habit of rounding up. If you've already injected, no action is needed unless side effects are severe.

Can I round 5 units up to 6 if my vial is 5 mg/mL?

A 1-unit rounding at 5 mg/mL adds 0.05 mg (20%). For the starter dose this is within typical clinical tolerance, but consistent rounding pushes titration faster than intended. Talk to your provider before rounding habitually.

What if I miss a dose?

Take it as soon as you remember if it's within 4 days. If more than 4 days have passed, skip and resume on your normal day. Don't double up.

Is the 0.25 mg dose the same for compounded and brand-name semaglutide?

The starter milligram dose is the same. The unit count differs because the brand-name pen (Wegovy) auto-doses at preset volumes, while compounded vials require manual draws.

Does the unit count change if my pharmacy switches to a B12-containing solution?

The B12 component takes up volume in the solution, so the semaglutide concentration is calibrated to deliver the same milligram dose at the same volume. The unit count for 0.25 mg of semaglutide doesn't change. Confirm with the pharmacy on the new label.

How accurate are insulin syringe markings at 10 units?

ISO 8537 specifies plus-or-minus 5% tolerance. For a 10-unit draw that's plus-or-minus 0.5 units, which is clinically irrelevant for semaglutide.

Why is my draw so small at 5 mg/mL?

0.25 mg of semaglutide at 5 mg/mL is 0.05 mL, or 5 units. That's a tiny volume on a U-100 syringe. If you find it hard to read accurately, ask your pharmacy to switch you to a 2.5 mg/mL vial for easier dosing during the starter period.

Author / review note

Reviewed by the FormBlends Medical Team. References include Wilding et al., New England Journal of Medicine, 2021 (STEP 1, semaglutide for obesity), Patel et al., Annals of Pharmacotherapy, 2024 (compounded GLP-1 dosing errors), the FDA prescribing information for semaglutide (Wegovy and Ozempic), and the U.S. Pharmacopeia chapter on insulin syringe accuracy (USP <1>).

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.